LAPSER1:: a novel candidate tumor suppressor gene from 10q24.3

被引:42
作者
Cabeza-Arvelaiz, Y
Thompson, TC
Sepulveda, JL
Chinault, AC [1 ]
机构
[1] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Urol, Houston, TX 77030 USA
[3] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA
关键词
prostate cancer; tumor suppressor; LZTS1; LAPSER1;
D O I
10.1038/sj.onc.1204866
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Numerous LOH and mutation analysis studies in different tumor tissues, including prostate, indicate that there are multiple tumor suppressor genes (TSGs) present within the human chromosome 8p21-22 and 10q23-24 regions. Recently, we showed that LZTS1 (or FEZ1), a putative TSG located on 8p22, has the potential to function as a cell growth modulator. We report here the cloning, gene organization, cDNA sequence characterization and expression analysis of LAPSER1, an LZTS1-related gene. This gene maps within a subregion of human chromosome 10q24.3 that has been reported to be deleted in various cancers, including prostate tumors, as frequently as the neighboring PTEN locus. The complete LAPSER1 cDNA sequence encodes a predicted protein containing various domains resembling those typically found in transcription factors (P-Box, Q-rich and multiple leucine zippers). LAPSER1 is expressed at the highest levels in normal prostate and testis, where multiple isoforms are seen, some of which are either undetectable or differentially expressed in some prostate tumor tissues and cell lines. Over-expression of LAPSER1 cDNA strongly inhibited cell growth and colony-forming efficiencies of most cancer cells assessed. Together these data suggest that LAPSER1 is another gene involved in the regulation of cell growth whose loss of function may contribute to the development of cancer.
引用
收藏
页码:6707 / 6717
页数:11
相关论文
共 42 条
[1]  
ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
[2]   Physical mapping of chromosome 8p22 markers and their homozygous deletion in a metastatic prostate cancer [J].
Bova, GS ;
MacGrogan, D ;
Levy, A ;
Pin, SS ;
Bookstein, R ;
Isaacs, WB .
GENOMICS, 1996, 35 (01) :46-54
[3]   Functional identification of LZTS1 as a candidate prostate tumor suppressor gene on human chromosome 8p22 [J].
Cabeza-Arvelaiz, Y ;
Sepulveda, JL ;
Lebovitz, RM ;
Thompson, TC ;
Chinault, AC .
ONCOGENE, 2001, 20 (31) :4169-4179
[4]   CLONING AND GENETIC-CHARACTERIZATION OF THE HUMAN KINESIN LIGHT-CHAIN (KLC) GENE [J].
CABEZAARVELAIZ, Y ;
SHIH, LCN ;
HARDMAN, N ;
ASSELBERGS, F ;
BILBE, G ;
SCHMITZ, A ;
WHITE, B ;
SICILIANO, MJ ;
LACHMAN, LB .
DNA AND CELL BIOLOGY, 1993, 12 (10) :881-892
[5]  
Cairns P, 1997, CANCER RES, V57, P4997
[6]   ALLELIC LOSS OF CHROMOSOME-16Q AND CHROMOSOME-10Q IN HUMAN PROSTATE-CANCER [J].
CARTER, BS ;
EWING, CM ;
WARD, WS ;
TREIGER, BF ;
AALDERS, TW ;
SCHALKEN, JA ;
EPSTEIN, JI ;
ISAACS, WB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (22) :8751-8755
[7]   PTEN/MMAC1 mutations in primary glioblastomas and short-term cultures of malignant gliomas [J].
Chiariello, E ;
Roz, L ;
Albarosa, R ;
Magnani, I ;
Finocchiaro, G .
ONCOGENE, 1998, 16 (04) :541-545
[8]   EMPIRICAL PREDICTIONS OF PROTEIN CONFORMATION [J].
CHOU, PY ;
FASMAN, GD .
ANNUAL REVIEW OF BIOCHEMISTRY, 1978, 47 :251-276
[9]   ANALYSIS OF SP1 INVIVO REVEALS MULTIPLE TRANSCRIPTIONAL DOMAINS, INCLUDING A NOVEL GLUTAMINE-RICH ACTIVATION MOTIF [J].
COUREY, AJ ;
TJIAN, R .
CELL, 1988, 55 (05) :887-898
[10]   PTEN/MMAC1 is infrequently mutated in pT2 and pT3 carcinomas of the prostate [J].
Dong, JT ;
Sipe, TW ;
Hyytinen, ER ;
Li, CL ;
Heise, C ;
McClintock, DE ;
Grant, CD ;
Chung, LWK ;
Frierson, HF .
ONCOGENE, 1998, 17 (15) :1979-1982